PharmaShots | Incisive News in 3 Shots

Subscribe Now

P-III (LIGHTHOUSE) Study

Biogen and Denali Report the Initiation of P-III (LIGHTHOUSE) Study for BIIB122 to Treat Parkinson’s Disease Associated with LRRK2 Pathogenic Mutations

Biogen and Denali Report the Initiation of P-III (LIGHTHOUSE) Study for BIIB122 to Treat Parkinson’s Disease Associated with LRRK2...

October 4, 2022

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us